Published in Contraception on November 17, 2008
Effect of dietary fiber intake on lipoprotein cholesterol levels independent of estradiol in healthy premenopausal women. Am J Epidemiol (2010) 1.44
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women. Am J Obstet Gynecol (2012) 0.98
New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control. Int J Womens Health (2010) 0.76
A chewable low-dose oral contraceptive: a new birth control option? Patient Prefer Adherence (2012) 0.75
A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Age-related testosterone depletion and the development of Alzheimer disease. JAMA (2004) 2.45
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril (2004) 2.33
Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol (2002) 2.27
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) (2006) 2.17
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial. Obstet Gynecol (2014) 2.01
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception (2010) 1.96
Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer (2012) 1.82
Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab (2006) 1.76
Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study. Contraception (2006) 1.68
Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab (2007) 1.66
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis (2008) 1.63
Insulin resistance and prostate cancer risk. J Natl Cancer Inst (2003) 1.61
Intrauterine contraception as an alternative to interval tubal sterilization. Contraception (2007) 1.59
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol (2011) 1.56
Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2006) 1.56
Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev (2007) 1.53
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception (2009) 1.52
Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause (2011) 1.50
Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab (2010) 1.46
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause (2014) 1.46
Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol (2006) 1.46
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril (2012) 1.45
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate (2003) 1.40
Reliability of extraction/chromatography RIAs. Clin Chem (2004) 1.40
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins. Contraception (2008) 1.34
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci U S A (2012) 1.26
Hormones and prostate cancer: current perspectives and future directions. Prostate (2002) 1.26
Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2005) 1.26
Strategy for standardization of preeclampsia research study design. Hypertension (2014) 1.25
Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.24
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol (2010) 1.23
Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception (2005) 1.21
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev (2012) 1.20
Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception (2009) 1.16
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging (2009) 1.14
Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomarkers Prev (2008) 1.14
Predictors of noncompliance in an oral contraceptive clinical trial. Contraception (2011) 1.13
Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev (2012) 1.12
Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis (2005) 1.12
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin Cancer Res (2006) 1.10
The postpartum visit: it's time for a change in order to optimally initiate contraception. Contraception (2008) 1.10
Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast (2005) 1.10
Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr (2009) 1.10
No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2005) 1.09
Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception (2010) 1.08
Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res (2010) 1.08
Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception (2005) 1.06
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Contraception technology: past, present and future. Contraception (2012) 1.06
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res (2004) 1.05
Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res (2004) 1.05
A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr (2005) 1.05
Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst (2009) 1.04
Incisional endometriomas after Cesarean section: a case series. J Reprod Med (2007) 1.04
Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer (2010) 1.04
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception (2012) 1.04
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril (2007) 1.02
Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab (2011) 1.02
Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) (2012) 1.02
Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res (2009) 1.01
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat (2007) 1.01
Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer (2011) 1.01
Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstet Gynecol Scand (2008) 0.99
Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer (2007) 0.99
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control (2011) 0.98
Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause (2015) 0.98
Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate (2002) 0.98
Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception (2004) 0.98
Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control (2009) 0.98
Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer (2011) 0.98
Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling. Cancer Res (2007) 0.97
Serum antimüllerian hormone in healthy premenopausal women. Fertil Steril (2011) 0.97
Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial. J Am Acad Dermatol (2002) 0.97
Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public Health Nutr (2006) 0.97
Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev (2002) 0.97
Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort. Prostate (2010) 0.97
Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States). Cancer Causes Control (2006) 0.97
Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum. J Womens Health (Larchmt) (2011) 0.97
Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A (2013) 0.97
Menopausal transition stage-specific changes in circulating adrenal androgens. Menopause (2012) 0.96
Androstenediol complements estrogenic bioactivity during the menopausal transition. Menopause (2012) 0.96